Why Guardant Health Stock Zoomed 10% Higher Today
Guardant Health (NASDAQ: GH) shareholders had a fine Thursday, as the cancer-diagnostics company's stock saw a 10% pop. This was thanks to its latest quarterly earnings report, which delivered a pair of extremely pleasant upside surprises.
Guardant Health's Q4 and full-year 2021 results, published after market hours Wednesday, revealed significant growth in several key metrics. Chief among these was revenue, which shot 38% higher year over year to $108 million. In sharp contrast, though, the company's non-GAAP (adjusted) net loss deepened to more than $70 million ($0.69 per share) from the year-ago shortfall that was just shy of $37 million.
Image source: Getty Images.
Source Fool.com
